TRPA1 and colitis: Importantly, genetic or pharmacological ablation of TRPA1 function suppresses both TNBS- and DSS-induce colitis, supporting a critical role of TRPA1-mediated SP release in the pathogenesis of colitis (Engel et al., 2011; Fig. 2).